Internal Medicine, Pulmonary Disease · Ann Arbor, MI
NPI
1831271741
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1500 E Medical Center Dr
Ann Arbor, MI, 48109
Phone (734) 936-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
740 services
Medicare patients, 2024
164
Average age 74
Drug cost, 2024
$5.0M
1,492 prescriptions
Company payments, 2025
$65K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin R Flaherty was code 94010 (pulmonary function testing), 230 times for 142 patients. In total Kevin R Flaherty billed 740 services in 11 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Facility | 230 | 142 | $5.79 | $1,332 |
| 94729 Pulmonary Function Testing | Facility | 197 | 134 | $6.29 | $1,240 |
| 99213 Office E&M - Established | Facility | 197 | 118 | $49.21 | $9,695 |
| 94618 Pulmonary Function Testing | Facility | 32 | 29 | $16.68 | $534 |
| 99205 Office E&M - New | Facility | 30 | 30 | $139.43 | $4,183 |
| 99214 Office E&M - Established | Facility | 15 | 15 | $77.72 | $1,166 |
| 94726 Pulmonary Function Testing | Facility | 12 | 12 | $9.28 | $111 |
By year: 2022 $27K for 855 services; 2023 $20K for 787 services; 2024 $19K for 740 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin R Flaherty prescribed most often to Medicare patients was Ofev (Nintedanib Esylate), with 314 prescriptions and refills. In total Kevin R Flaherty wrote 1,492 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofev Nintedanib Esylate | 314 | 318 | 41 | $4.2M |
| Pirfenidone Generic | 168 | 168 | 28 | $600K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 157 | 332 | 40 | $797 |
| Prednisone Generic | 132 | 247 | 32 | $910 |
| Tacrolimus Generic | 85 | 154 | 15 | $8,415 |
| Omeprazole Generic | 71 | 153 | 18 | $1,113 |
| Azithromycin Generic | 54 | 124 | 29 | $670 |
| Acyclovir Generic | 46 | 98 | 13 | $381 |
| Azathioprine Generic | 39 | 97 | Under 11 | $1,872 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 29 | 31 | 13 | $1,085 |
| Eliquis Apixaban | 27 | 57 | Under 11 | $31K |
| Atorvastatin Calcium Generic | 27 | 81 | Under 11 | $420 |
| Mycophenolate Mofetil Generic | 27 | 38 | Under 11 | $2,548 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 25 | 31 | Under 11 | $19K |
| Metoprolol Tartrate Generic | 23 | 53 | Under 11 | $222 |
Brand drugs: - claims; generic drugs: 1,042 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin R Flaherty $65K ($65K in general payments such as food, travel and fees) from 6 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $30K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.